Kula Investments »

Arrowhead Pharmaceuticals shares owned by Kula Investments

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Kula Investments from 13F filings

Historical chart of Kula Investments investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Kula Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Kula Investments

Quarter filed Position value Share count Share price at filing
2023-03-31 $732k 29k 25.40

More positions owned by Kula Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
W.R. Berkley Corporation (WRB)
General Motors Company (GM)
Western Union Company (WU)
NetApp (NTAP)
Allstate Corporation (ALL)
Hilton Worldwide Holdings (HLT)
ConocoPhillips (COP)
Abbott Laboratories (ABT)
Genuine Parts Company (GPC)
Union Pacific Corporation (UNP)
Marriott Intl Cl A (MAR)
Mastercard Incorporated Cl A (MA)
Johnson & Johnson (JNJ)
Las Vegas Sands (LVS)

View all positions for Kula Investments

Top funds holding Arrowhead Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Credit Suisse
Norges Bank Investment Management
Rokos Capital Management
Artal Group
venBio Select Advisor
Goldman Sachs Group
Bank of New York Mellon
Ubs Global Asset Management Americas
Aquilo Capital Management
Charles Schwab Investment Management
Western Financial Corp
Avidity Partners Management
E. Ohman J:or Asset Management AB

View all funds holding Arrowhead Pharmaceuticals